Introduction
Receptors for advanced glycation end-products (RAGE) propagate intracellular signaling programs following interaction with a diversity of ligands. As members of the immunoglobulin superfamily of surface pattern recognition receptors, RAGE is often considered a potent initiation factor that functions in a focal fashion. Despite acute influences, RAGE has also increasingly been implicated as a progression factor in response to the availability of advanced glycation end-products (AGEs) that accumulate during oxidant stress and when endogenous ligands including S100/calgranulins, amyloid-β-peptide, and high mobility box protein 1 (HMGB1) are augmented [
1]-[
3]. RAGE is physiologically expressed in membranes of alveolar type I epithelial cells [
4] and macrophages where its signaling programs serve as an early response to perturbation. Furthermore, viscous feedback loops are common when pulmonary and non-pulmonary inflammatory lesions up-regulate RAGE signaling intermediates following stimulation [
1],[
3],[
5],[
6].
A series of publications clearly outline discoveries that demonstrate elevated RAGE expression and signaling by pulmonary cell types when extrinsic particulates including tobacco smoke are present [
7]-[
10]. In particular, RAGE expression mediates cytokine elaboration via Ras, a GTPase that influences MAP kinase signaling intermediates that modulate the expression of pro-inflammatory NF-κB target genes [
11],[
12]. Because RAGE and its ligands are biosynthetically up-regulated by tobacco smoke exposure, active RAGE signaling may cooperate in combined cellular responses associated with smoke-induced pulmonary inflammation. Furthermore, RAGE is significantly increased in distal lung tissue of smokers [
13]-[
15] and in the proximal airways of asthmatics that experience proximal lung inflammation [
16]. It is therefore clear that a lucid understanding of the molecular aspects of RAGE signaling in the lung is critical, particularly in the sensitive upper airways of susceptible individuals.
Proximal airway inflammation and impaired airflow are inflammatory characteristics that affect 23 million Americans. Airway inflammation involves a complex interaction of cells, cytokines, chemokines and other mediators. Immune and nonimmunologic environmental factors including primary and secondhand smoke (SHS) are important triggers of proximal airway inflammation [
17]. Approximately 25% to 35% of individuals with airway inflammation are current smokers [
18]. It is evident that smoking or exposure to SHS increase airway sensitivity and elevate proximal airway morbidity and disease severity [
17]. Prolonged exposure to tobacco smoke in patients with airway disease contributes to a decline in lung function: approximately 18% in forced expiratory volume in 1 second (FEV
1) over 10 years [
19]. Interestingly, asthmatic patients who smoke share features similar to those found in the early stages of emphysema [
20]; therefore RAGE signaling observed in emphysema may also, at least in part, impact airway pathogenesis [
9]. SHS from smoking parents is associated with increased airway hypersensitivity and other respiratory symptoms among school children. SHS from parents' smoking habits also is associated with more severe disease among those children with already established asthma [
21],[
22]. Even exposure to "light cigarette smoking" (≤10 cigarettes per day) can cause children who have airway inflammation to experience an increase of wheezing illness, especially during the first year of life, and to decreased lung function in children up to 6 years of age [
23]. Because there is a clear role for RAGE in primary and SHS exposure, research into airway exacerbations by tobacco smoke should include an evaluation of RAGE biology in the proximal lung. As such, it is critical to examine how RAGE target genes influence disease presentation so that precise mechanisms that coordinate and maintain airway inflammation can be identified.
In the current study we test the hypothesis that increased RAGE expression specifically by proximal airway epithelium results in elevated inflammation. Through the utilization of a double transgenic mouse model that conditionally overexpresses RAGE in conducting airway epithelium, we demonstrate that RAGE augmentation in the absence of any additional particulate exposure leads to airway inflammation coincident with leukocyte extravasation and cytokine secretion. These data offer evidence that short-term conditional RAGE overexpression is sufficient to induce an inflammatory response; however, additional research is needed to investigate the broader applications of this model. For example, additional studies that explore a lengthened time course may demonstrate that persistent RAGE elevation in the proximal lung coordinates more robust pulmonary remodeling events. These and other studies may reveal that RAGE and its intermediates are potential targets in the treatment or prevention of chronic inflammatory airway diseases, particularly those exacerbated by tobacco smoke such as asthma, bronchiectasis, and chronic bronchitis.
Discussion
The present investigation explores the basis of RAGE function in the proximal airways and demonstrates the manifestation of inflammatory characteristics with persistent RAGE availability. The plausibility that RAGE participates in airway inflammation is only a recent development; however, research from multiple independent laboratories has demonstrated that RAGE expression increases in the airways of sensitized, inflamed lungs. For example, research by Ullah et al. reveled that RAGE and HMGB1 were both augmented in the allergic airway and that the activation of a RAGE-HMGB1 signaling axis in response to various allergens mediated allergic airway sensitization [
16]. Additional research that employed blocking antibodies against HMGB1 led to the discovery that airway inflammation was ameliorated in ovalbumin (OVA)-immunized mice with hypersensitive airways [
34]. Specifically, HMGB1 abrogation led to significantly less inflammatory cell abundance, mucus secretion, and collagen deposition characteristic of asthmatic lung remodeling [
34]. Milutoinovic et al. also recently demonstrated that the inflammatory profiles in RAGE null mice were lessened following house dust mite and OVA-induced asthma pathogenesis [
35]. These experimental outcomes support the theme that RAGE signaling inhibition may provide a promising therapeutic strategy in the alleviation of proximal airway inflammatory diseases.
Increased leukocyte abundance in the airways of RAGE TG mice was observed despite no abnormal lung remodeling compared to controls. These observations were consistent with human studies that involved the characterization of induced sputum from normal healthy individuals compared to patients with airway inflammation [
36]. In particular, patients identified by higher Asthma Control Questionnaire (ACQ) results expressed significantly higher neutrophil numbers that were associated with elevated HMGB1 and RAGE expression [
36]. Interestingly, a newly developed viral-induced mouse model of airway inflammation revealed a similar neutrophilic inflammatory profile in BALF assessments coincident with no abnormal lung histology [
37]. While our research identifies that a short-term period of RAGE up-regulation was sufficient to induce airway inflammation, chronic studies using this model should be designed to test whether lung remodeling observed in prolonged inflammatory conditions is induced. For instance, a more chronic assessment may lead to significant increases in eosinophil counts that, with higher PMN numbers, cause histopathological remodeling of the airway. Moreover, phenotypic characterization of other leukocytes including lymphocytes and macrophages would prove insightful when considering causes of RAGE-mediated airway inflammation.
While we did not detect a significant increase in Th2 cytokines after 40 days, we observed elevated expression of TNF-α, IL-7, and IL-14 in RAGE TG mouse lungs compared to controls. TNF-α is the prototypic ligand of the TNF superfamily [
38]. It is a pleiotropic molecule that centrally functions in inflammation, immune system development, apoptosis, and lipid metabolism [
39]. In addition to inflammatory lung functions, TNF-α is also involved in a number of severe pathological conditions including Crohn's disease, rheumatoid arthritis, neuropathic pain, obesity, type 2 diabetes, septic shock, autoimmunity, and cancer [
40]. IL-7 was originally discovered as a growth factor produced by stromal cells that aided in the proliferation of precursor B-lymphocytes [
41]. In addition to being produced by bone marrow stromal cells, IL-7 mRNA has also been detected in spleen, thymus, kidney, and epithelial cells [
42]. Functionally, IL-7 has been shown to have pleiotropic effects on a variety of cell types, including cells of the B-, T-, NK-, and myeloid lineages [
40]. Although less studied, IL-14 primarily enhances immune cell proliferation and it is thought to partner with TNF-α during inflammatory signaling [
43]. It remains possible that Th2 related cytokines associated with eosinophilic inflammation are increased with more prolonged RAGE over-expression in the proximal lung. Accordingly, the activation of other T cell responses such as those associated with Th1, T reg, and Th17 should be considered. These responses may contribute to the refining of common Th2 responses plausibly controlling Th2-mediated eosinophil abundance trending higher after just 40 days of RAGE up-regulation. A more thorough inspection of these responses, together with Th17 modulators such as IL-17A, IL-17 F, IL17AF, IL-21, and IL-22 should be undertaken in future analyses of long term RAGE over-expressing mice.
Our discoveries related to increased TNF-α, IL-7 and IL-14 expression in RAGE TG mice supports previous research in the areas of airway inflammation disease diagnosis and progression. Thomas et al. demonstrated that TNF-α exacerbates airway sensitivity by controlling neutrophilia and it cooperates with IL-14 in increasing airway responsiveness [
43]. Complimentary studies revealed that IL-7 was increased by airway epithelial cells following exposure to environmental particulates with diameters that are less 2.5 μm known to promote asthma [
44]. Furthermore, IL-7 centrally functioned in the recruitment of eosinophils in chronic airway inflammatory events [
45]. A link clearly exists between the current RAGE TG mice and previously published studies that thematically describe inflammatory programs involving TNF-α, IL-7 and IL-14 [
43],[
46].
In conclusion, the present study revealed that conditional genetic up-regulation of RAGE in the proximal airways leads to the induction of an inflammatory response. RAGE up-regulation for 40 days caused expanded extravasation of leukocytes and elevated expression of cytokines implicated in inflammatory pathogenesis. The data revealed that a short period of RAGE expression was sufficient to initiate inflammation; however, further research defining cellular mechanisms that function during chronic RAGE up-regulation may aid in clarifying a more accurate model of airway inflammatory disease. Further elucidation of the sufficiency of RAGE signaling in the airways may lead to strategies for attenuating proximal airway inflammatory diseases.
Acknowledgments
Dr. Jeffrey A. Whitsett at the Cincinnati Children’s Hospital Medical Center kindly provided the CCSP-rtTA mice critical for the studies. The authors also acknowledge a team of undergraduates at Brigham Young University including Geraldine Rogers and Michael Chavarria for assistance in histology experiments and Michael P. Ryder, Sean C. Mabey, and Nataly Bullock for invaluable assistance with mouse husbandry and molecular mouse identification.
This work was supported by a grant from the Flight Attendant’s Medical Research Institute (FAMRI, P.R.R.) and a BYU Mentoring Environment Grant (P.R.R.).
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.
The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
BGB, BGB, and EL assisted in experimental design, maintained animals, and performed surgeries. AJW and ZRJ performed the immunoblotting and CMJ conduced the qPCR experiments. FRJ conduced cDNA arrays and assisted in data interpretation. CJE BGB, and BGB performed the immunohistochemistry and BALF analyses. JPJ and SMK were responsible for animal husbandry and genetic identification. PRR conceived of the study and supervised in its implementation, interpretation, and writing. All authors assisted in manuscript preparation and approved of the final submitted version.